VENUS REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 388.8 INR | +2.05% |
|
+2.22% | -4.30% |
| 06-13 | Venus Remedies Bags Tender from UNICEF for Antibiotic Ceftriaxone | MT |
| 05-30 | Venus Remedies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 848B | ||||||
| 627B | ||||||
| 363B | ||||||
| 318B | ||||||
| 299B |
